New Treatment for Non-Hodgkins Lymphoma - American Cancer Society Research into the causes, prevention, and treatment of non-Hodgkin lymphoma (NHL) is being done in many medical centers throughout the world Scientists are making a lot of progress in understanding how changes in the DNA inside normal lymphocytes can cause them to develop into lymphoma cells
Advances in Lymphoma Research - NCI - National Cancer Institute Find what's new in Hodgkin lymphoma and non-Hodgkin lymphoma (NHL) treatment and research, including progress on targeted therapies and immunotherapies Selected NCI-supported lymphoma programs are also described
Recent findings and future directions in non-Hodgkins lymphoma therapy Immune blockade therapy isn't nearly as effective as a sole treatment for non-Hodgkin's lymphomas compared with Hodgkin's lymphoma Mayo Clinic researchers see potential for this therapy in combination with others
Fighting lymphoma: Treatment options include alternatives to . . . For certain types of non-Hodgkin lymphoma, radiation therapy may be the only treatment you need, particularly if your lymphoma is slow growing and located in just one or two spots More commonly, radiation is used after chemotherapy to kill any lymphoma cells that might remain
Non-Hodgkin Lymphoma Treatment - NCI - National Cancer Institute Most types of non-Hodgkin lymphoma begin in B lymphocytes T lymphocytes that help B lymphocytes make the antibodies that help fight infection Also called T cells Natural killer cells that attack cancer cells and viruses Also called NK cells
New drug treatment for CLL and NHL showing promise A new drug treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin’s lymphoma (NHL) is showing promise during clinical trials Learn more about nemtabrutinib
Non-Hodgkin Lymphoma Treatment - MD Anderson Cancer Center One or more of the following therapies may be recommended to treat the cancer or help relieve symptoms Chemotherapy kills fast-growing cells, including cancer cells This is the treatment most often used for non-Hodgkin lymphoma